Ekso Bionics Inc.

AI Score

0

Unlock

0.69
-0.02 (-3.10%)
At close: Jan 14, 2025, 3:59 PM
0.69
-0.72%
Pre-market Jan 15, 2025, 06:57 AM EST
undefined%
Bid 0.69
Market Cap 15.29M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -0.64
PE Ratio (ttm) -1.09
Forward PE n/a
Analyst Buy
Ask 0.71
Volume 640,126
Avg. Volume (20D) 986,000
Open 0.74
Previous Close 0.71
Day's Range 0.67 - 0.74
52-Week Range 0.50 - 2.50
Beta undefined

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices t...

Sector Healthcare
IPO Date Jan 17, 2014
Employees 70
Stock Exchange NASDAQ
Ticker Symbol EKSO

Analyst Forecast

According to 2 analyst ratings, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is $5.5, which is an increase of 691.37% from the latest price.

Buy 100.00%
Hold 0.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Ekso Bionics Inc. is scheduled to release its earnings on Mar 3, 2025, during market hours.
Analysts project revenue of $5.30M, reflecting a 9.35% YoY growth and earnings per share of -0.08, making a -63.64% decrease YoY.
2 months ago · Source
-15.03%
Ekso Bionics shares are trading lower after Lake S... Unlock content with Pro Subscription
5 months ago · Source
-28.86%
Esko Bionics Holdings shares are trading lower after the company reported worse-than-expected Q2 sales results.